SERA PROGNOSTICS, INC. cotiza a 2.05 USD y tiene una capitalización bursátil de $81M. En los últimos 12 meses ha facturado $70000 con un margen de flujo de caja libre del -32529.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Sera Prognostics, Inc., a women's health company, discovers, develops, and commercializes blood-based biomarker tests, and predictive analytic products and services in the United States. The company develops the PreTRM test, a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 t…
| Métrica | SERA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | -102.5% | 57.0% | -159.5% |
| Operating Margin | -45066.7% | -38.6% | -45028.0% |
| Net Margin | -39417.3% | -33.6% | -39383.7% |
| FCF Margin | -32529.6% | -13.9% | -32515.8% |
| ROE | -42.3% | -40.4% | -1.9% |
| ROA | -31.3% | -32.0% | +0.7% |
| Current Ratio | 1.69 | 2.84 | -1.15 |
| Debt / Equity | — | 0.28 | — |